Qual é o preço para BillionToOne, Inc. (BLLN)

O preço para BillionToOne, Inc. (BLLN) é $99.89

Qual é a capitalização de mercado para BillionToOne, Inc. (BLLN)

A capitalização de mercado para BillionToOne, Inc. (BLLN) é $4.59B

BillionToOne, Inc. (BLLN) Preço e Capitalização de Mercado

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Preço para BLLN	Ativo B	Capitalização de mercado de B	Resultados
$112,021 $4.59B	NVDA	$5.152T	+112,045.64%
$98,640.39 $4.59B	AAPL	$4.537T	+98,649.80%
$90,629.77 $4.59B	GOOG	$4.169T	+90,630.29%
$79,189.16 $4.59B	MSFT	$3.642T	+79,177.00%
$60,977.70 $4.59B	AMZN	$2.805T	+60,945.34%

Preço para BLLN

Ativo B

Capitalização de mercado de B

Resultados

$112,021 $4.59B